NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 164 filers reported holding NXSTAGE MEDICAL INC in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $74,000 | -76.3% | 2,600 | -76.6% | 0.02% | -59.3% |
| Q3 2018 | $312,000 | +155.7% | 11,100 | +152.3% | 0.06% | +110.7% |
| Q2 2018 | $122,000 | +293.5% | 4,400 | +238.5% | 0.03% | +300.0% |
| Q4 2017 | $31,000 | -87.8% | 1,300 | -86.3% | 0.01% | -75.9% |
| Q1 2017 | $255,000 | -16.4% | 9,500 | -18.5% | 0.03% | -25.6% |
| Q4 2016 | $305,000 | -14.1% | 11,650 | -18.0% | 0.04% | -15.2% |
| Q3 2016 | $355,000 | +219.8% | 14,200 | +178.4% | 0.05% | +206.7% |
| Q2 2016 | $111,000 | – | 5,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |